Office of Research & Development
The CSRD Data Monitoring Committee (DMC) monitors CSRD clinical studies that are approved for funding, include human subjects, and may involve randomization. The CSRD DMC provides an ongoing independent evaluation of the progress of studies, including participant accrual and retention, adverse events monitoring, and analysis plan. DMC review is separate and distinct from Institutional Review Board (IRB) review and approval. The DMC will not evaluate the scientific merit, methodology, or overall design, and budgetary constraints of an IRB approved protocol under review, except where changes to the protocol may result in a change in safety level or monitoring.
Tamara Paine, MA, MS, DBA
Lucindia Shouse, MS